Session Information
2007 BIO International Convention
Click here to go to the previous page
What Can Happen When Patient Advocates and Corporations Work Together
Track : Policy
Program Code: POL030
Date: Monday, May 7, 2007
Time: 2:00 PM to 3:30 PM  
Location: 205 C
CHAIR :
Elliott Hillback, , Senior Vice President, Corporate Affairs, Genzyme Corporation
SPEAKER (S):
Orkideh Malkoc, Associate Director of Public Policy, Genetic Alliance
Erik Tambuyzer, Senior Vice President, Corporate Affairs Europe & International, Genzyme Corporation
Robert Wells, Vice President, International Markets Group & Corporate Affairs, Affymetirc, Inc.
Brian Petersen, Deputy Legislative Director, Congresswoman, Judy Biggert (IL-13)
Alastair Kent, Director, Genetic Interest Group (GIG)
Description
Increasingly patients and the advocacy organizations they create are effectively collaborating with health-care industry partners on a wide range of important public policy topics. Experienced leaders of advocacy groups, corporations and government organizations from the United States and Europe who are at the cutting edge of this trend will share their proven collaboration methods and discuss the positive results.



Objectives:
  • Discuss successful public policy collaborations.

  • Learn how to build collaborative relations with other partners.

  • Understand how to achieve results that are mutually positive.


  • Streaming Audio with
    PowerPoint Slides
    (Code: POL030)
      
    This session is a part of: